Mass General Hospital to Genetically Test All Cancer Patients within One Year | GenomeWeb

In an attempt to further validate genetic mutations linked to cancer, Massachusetts General Hospital Cancer Center plans to start off genetically testing lung cancer patients, and eventually test all patients that come to the hospital with a positive biopsy or a tumor.

"Genetic fingerprinting is currently being offered to our lung cancer group," said Darrell Borger, co-director of Mass General's new Translational Research Lab where the genetic profiling will be conducted.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.